• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Protagen

edit

Protagen is a leading provider of services, products and software solutions for protein research.

With a highly experienced and motivated team Protagen provides products and GMP compliant services of outstanding quality.

The patented platform of protein expression libraries UNIclone® is one of the technology innovations of Protagen. This highly efficient technology platform allows Protagen the development of a new class of diagnostics based on autoantibody signatures in blood.

Protagen serves customers around the globe and has offices in Dortmund, Germany, and Chester, New Jersey, USA.

Recent Milestones

edit

• 
  Protagen received $12.7M in Series B funding. (9/7/10)
  Posted 9/8/10 at 6:15pm via genomeweb.com
• 
  Protagen received $5.33M in Venture Round funding. (8/3/09)
  Posted 9/29/09 at 2:03am via protagen.de
• 
  Protagen received $1.49M (€1M) in Venture Round funding. (1/15/08)
  Posted 12/17/09 at 5:21am via protagen.de
• 
  Protagen received $4.21M (€3.3M) in Series B funding. (5/8/06)
  Posted 4/27/10 at 3:56am via protagen.de

Videos

Screenshots

edit

Above: Protagen Screenshot -- #1
Uploaded: 9/29/09

Sources

1. Protagen AG closes second round of financing with old and new investors (protagen.de) [edit]
2. Protagen raises €1 million to expand its protein biochips business unit (protagen.de) [edit]
3. Protagen closes new Round of Financing for the Development of molecular Diagnostics for Prostate Cancer and Multiple Sclerosis (protagen.de) [edit]
4. Protagen Raises $12.7M in Private Financing (genomeweb.com) [edit]